HDAC2 inhibitors (Alkermes)

N/A

Report date: 2025/03/20 14:45:19
NME

Base Information

Drug NameHDAC2 inhibitors (Alkermes)
Drug Alias NameHDAC2 inhibitors (Rodin)selective epigenetic modulators (Rodin)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 2 inhibitors
TargetsHistone deacetylase 2
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRodin Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlkermes Plc
Inactive CompaniesRodin Therapeutics Inc
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A